457
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Direct and indirect costs among employees with diabetic retinopathy in the United States*

, , , , , & show all
Pages 1549-1559 | Accepted 12 Mar 2008, Published online: 15 Apr 2008
 

ABSTRACT

Objective: To examine, from the employer perspective, the direct (healthcare) and indirect (workloss) costs of employees with diabetic retinopathy (DR) compared to control non-DR employees with diabetes, and within DR subgroups.

Methods: Compared annual costs using claims data from 17 large companies (1999–2004). ‘DR employees’ (n = 2098) had ≥ 1 DR (International Classification of Disease, 9th Revision [ICD‑9]) diagnosis; DR subgroups included employees with diabetic macular edema (DME), proliferative DR (PDR), and employees receiving photo­coagulation or vitrectomy procedures. Descriptive and multivariate tests were performed.

Results: DR employee annual direct costs were $18 218 (indirect = $3548) compared to $11 898 (indirect = $2374) for controls (Δ = $2032 (adjusted); p < 0.0001). Costs differences were larger across DR employee subgroups: DME/non-DME ($28 606/$16 363); PDR/non-PDR ($30 135/$13 445; p < 0.0001); DR with/without photocoagulation ($34 539/$16 041; p < 0.0001); and DR with/without vitrectomy ($63 933/$17 239; p < 0.0001).

Limitations: This study examined the incremental costs of treating DR employees, which may be higher than the incremental costs of DR itself. Some measures of diabetes severity (e.g., duration of diabetes) were not available in the claims data, and were therefore not included in the multivariate models. The cost of photocoagulation and vitrectomy procedures pertain to individuals who underwent these procedures, and not the cost of the procedures themselves.

Conclusion: DR employees had significantly higher costs than controls, and larger differences existed within DR subgroups. Indirect costs accounted for about 20% of total cost.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.